{"id":"W4220833656","doi":"10.1158/1538-7445.sabcs21-p4-10-01","title":"Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Palbociclib; Breast cancer; Clinical endpoint; Quality of life (healthcare); Internal medicine; Adjuvant; Cancer; Randomized controlled trial; Interim analysis; Adjuvant therapy; Oncology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00280705,0.001515372,0.001690311,0.0003777758,0.0003334529,0.001347328,0.001120895,0.001002815,0.008926856],"category_scores_gemma":[0.001711606,0.0004539702,0.002000218,0.0003896999,0.001021413,0.0008515672,0.0006376268,0.004189014,0.0007108878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010465,"about_ca_system_score_gemma":0.001648413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001192077,"about_ca_topic_score_gemma":0.001924747,"domain_scores_codex":[0.9988563,0.0007808664,0.0000517304,0.000127247,0.00008059637,0.000103257],"domain_scores_gemma":[0.9987888,0.0002696616,0.0003312835,0.0000628832,0.00006389028,0.0004835719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9818453,0.003272299,0.001183218,0.0003391602,0.0006903612,0.00002460629,0.00001643369,0.0003547361,0.001062525,0.00009465843,0.001595284,0.00952148],"study_design_scores_gemma":[0.9415949,0.05294395,0.003126314,0.00003556143,0.0004986288,0.00003225709,0.00001687288,0.0005820237,0.0002661728,0.0001615093,0.0007293855,0.00001239663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807228,0.00561241,0.0005237052,0.001998499,0.0006169408,0.003118941,0.002691976,0.0001659098,0.004548758],"genre_scores_gemma":[0.9834337,0.001637168,0.001441889,0.001388341,0.0006461887,0.004286421,0.002969055,0.00002034976,0.004176783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008926856,"threshold_uncertainty_score":0.02986336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07693271054620061,"score_gpt":0.422743662923142,"score_spread":0.3458109523769414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}